Nanexa AB engages in the development, production, and distribution of medical nanotechnology products. The firm's product, PharmaShell, provides possibilities for drug administration, dosage, and for targeting of parenteral drugs. It also offers Nanexa gas barrier and antifungal coating. The company was founded by Mats Boman, Jan-Otto Carlsson, Christian Östberg, Anders Hårsta, Mårten Rooth, Jessica Östberg, and Anders Johansson in 2007 and is headquartered in Uppsala, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company